Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP530724.RA99ePBPswRCS6Eu_IkC1A-ZKQ1Xv3mh25EMMG7viGZxg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP530724.RA99ePBPswRCS6Eu_IkC1A-ZKQ1Xv3mh25EMMG7viGZxg130_assertion type Assertion NP530724.RA99ePBPswRCS6Eu_IkC1A-ZKQ1Xv3mh25EMMG7viGZxg130_head.
- NP530724.RA99ePBPswRCS6Eu_IkC1A-ZKQ1Xv3mh25EMMG7viGZxg130_assertion description "[These observations suggest that increase of CSF HVA might be necessary for clinical improvement of choreiform movement but not correlate with the degree of improvement and dopamine agonists could be useful drug for the treatment of choreiform movement which is refractory to the administration of neuroleptics.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP530724.RA99ePBPswRCS6Eu_IkC1A-ZKQ1Xv3mh25EMMG7viGZxg130_provenance.
- NP530724.RA99ePBPswRCS6Eu_IkC1A-ZKQ1Xv3mh25EMMG7viGZxg130_assertion evidence source_evidence_literature NP530724.RA99ePBPswRCS6Eu_IkC1A-ZKQ1Xv3mh25EMMG7viGZxg130_provenance.
- NP530724.RA99ePBPswRCS6Eu_IkC1A-ZKQ1Xv3mh25EMMG7viGZxg130_assertion SIO_000772 7938569 NP530724.RA99ePBPswRCS6Eu_IkC1A-ZKQ1Xv3mh25EMMG7viGZxg130_provenance.
- NP530724.RA99ePBPswRCS6Eu_IkC1A-ZKQ1Xv3mh25EMMG7viGZxg130_assertion wasDerivedFrom befree-20150227 NP530724.RA99ePBPswRCS6Eu_IkC1A-ZKQ1Xv3mh25EMMG7viGZxg130_provenance.
- NP530724.RA99ePBPswRCS6Eu_IkC1A-ZKQ1Xv3mh25EMMG7viGZxg130_assertion wasGeneratedBy ECO_0000203 NP530724.RA99ePBPswRCS6Eu_IkC1A-ZKQ1Xv3mh25EMMG7viGZxg130_provenance.